Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-ca13-14-01838/USCOURTS-ca13-14-01838-0/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 

---

NOTE: This disposition is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

AVANIR PHARMACEUTICALS INC.,

Plaintiff-Appellee

AVANIR HOLDING COMPANY, CENTER FOR 

NEUROLOGICAL STUDY,

Plaintiffs

v.

PAR PHARMACEUTICAL INC., PAR 

PHARMACEUTICAL COMPANIES INC.,

Defendants-Appellants

______________________ 

2014-1838

______________________ 

Appeal from the United States District Court for the

District of Delaware in No. 1:11-cv-00704-LPS, Chief 

Judge Leonard P. Stark.

______________________ 

JUDGMENT

______________________ 

F. DOMINIC CERRITO, Quinn Emanuel Urquhart & 

Sullivan, LLP, New York, NY, argued for plaintiffappellee. Also represented by ERIC C. STOPS, EVANGELINE 

SHIH, DANIEL C. WIESNER. 

Case: 14-1838 Document: 59-2 Page: 1 Filed: 08/10/2015
 

JANINE A. CARLAN, Arent Fox, LLP, Washington, DC, 

argued for defendants-appellants. Also represented by

RICHARD J. BERMAN, AZIZ BURGY, TANIEL ERMANO 

ANDERSON, STEPHEN YANG. 

______________________ 

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED: 

 PER CURIAM (CHEN, LINN, and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

 ENTERED BY ORDER OF THE COURT

August 10, 2015 /s/ Daniel E. O’Toole 

 Date Daniel E. O’Toole 

 Clerk of Court

Case: 14-1838 Document: 59-2 Page: 2 Filed: 08/10/2015